Waterloo, March 10, 2025 – With a 44% increase in revenue compared to the previous year, Canadian manufacturer KA Imaging ended 2024 on a strong note. “Our results reflect the commitment of our team, who has been working hard in product development and sales,” said Amol Karnick, president and CEO of KA Imaging. In addition to the revenue growth, KA also reported a 16% expansion in staff.
Key Product Launches in 2024
KA Imaging expanded its product portfolio in 2024 with the launch of the Reveal Mobi Pro, a premium dual-energy mobile system that redefines bedside imaging. The system, developed in collaboration with Del Medical, Inc., received clearance from both the U.S. FDA and Health Canada, marking a significant milestone for mobile imaging solutions. The product has also received the CE Mark.
On the NDT (Non-destructive Testing) side, two new products were introduced to the market: Reveal R 35C and inCiTe 2.0.
The Reveal™ R 35C is a ruggedized version of its triple-energy X-ray detector, designed for non-destructive testing (NDT) in harsher industrial environments. The detector features a reinforced enclosure that enables reliable performance in challenging conditions, while still offering the patented SpectralDR® technology.
The inCiTe 2.0 3D X-ray Microscope is an innovative micro-CT system that integrates both phase contrast and spectral imaging capabilities. Designed for industrial and research applications, inCiTe 2.0 offers high-resolution imaging for non-destructive testing, making it an alternative to traditional Scanning Electron microscopy (SEM).
Pushing Boundaries in Research
Studies conducted by independent researchers using KA’s technology have yielded groundbreaking results.
At Argonne National Laboratory, a multi-institutional research team used KA Imaging’s BrillianSe™ X-ray detector for a new application in Dark Field X-ray Microscopy (DFXM). This breakthrough technique, which investigates weak diffraction signals in magnetic systems, quantum materials, and thin films, relies on the BrillianSe™ detector’s direct detection capabilities. By achieving an order-of-magnitude improvement in exposure times compared to traditional scintillator-based methods, researchers can now image weakly diffracting ordered systems with greater speed and precision. This advancement opens new possibilities for nanoscale resolution imaging in the hard X-ray range, pushing the limits of scientific discovery.
Another group of research based out of Johns Hopkins University demonstrated that a three-layer flat panel detector – the Reveal 35C – may be able to be used for BMD quantification. The researchers wanted to discuss the potential role for Reveal to be used to perform opportunistic BMD quantification given its low radiation dose and higher accessibility. Overall, the Reveal 35C showed promising accuracy with less than 10% error relative to DEXA scan. The study, presented at RSNA 2023, sparked discussions among radiologists throughout 2024.
New Clinical Trials and Research Publications
KA Imaging further strengthened its clinical impact with the release of new clinical trials and research publications in 2024. At the American Society of Emergency Radiology (ASER) conference, a study was presented highlighting the impact of KA Imaging’s technology on ICU workflows. The results demonstrated how the use of KA Imaging’s Reveal 35C can provide better image quality, same reading times or faster, increased confidence in diagnosis, reduced time to potential intervention, and potential to divert cases from CT imaging.
Additionally, KA Imaging’s work on cardiac health was published in the Canadian Association of Radiologists Journal (CARJ). The study focused on the detection of cardiac calcifications using KA Imaging’s dual-energy X-ray technology, offering new insights into the early identification and monitoring of cardiovascular disease.
Expanding Global Access to Healthcare
In collaboration with the Kenyan Kids Foundation Canada, KA Imaging played a vital role in enhancing healthcare access in rural Kenya. By installing the Reveal 35C detector along with an X-ray source, the company brought SpectralDR imaging to a region with limited medical infrastructure, creating a lasting impact on community health.
2025: 10 years of innovation with eyes on the future
Looking ahead to 2025, the company anticipates further global expansion in both medical and NDT markets.
In R&D, the company is actively working on Artificial Intelligence (AI) integration. “AI is a hot topic, but it’s only as good as the data it’s trained on,” said Karim S. Karim, CTO at KA Imaging. “With our three-layer SpectralDR detector, we provide significantly more data than anyone else—leading to better AI outcomes,” he said.
As KA Imaging marks its 10th anniversary, the founders reaffirm their commitment to innovation. “When we started 10 years ago, many industry experts told us that what we were trying to do was impossible. We are proud to have proven them wrong,” said Karnick. “Can’t wait to unveil our next projects,” he said.